mAbDx granted IACUC approval for the development of monoclonal antibodies and immunoassays to identify and study mitochondrial DAMPs. Project title:  “Defining the contribution of mitochondrial damage-associated-molecular patterns (mtDAMPs) to the systemic inflammatory response syndrome (SIRS) after tissue injury”.